Magnesium Hydroxide Suspension
NDC Package 84447-113-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Magnesium Hydroxide suspension is a medication used for a short time to treat occasional constipation. This formulation utilizes a suspension delivery system. Marketed by Belleview Biosciences Llc, this product is identified by NDC 84447-113.

Identification & Billing

NDC Package Code
84447-113-01
Package Description
16000000 mg in 1 DRUM
Product Code
11-Digit Billing Format
84447011301

Clinical Specifications

Proprietary Name
Magnesium Hydroxide
Non-Proprietary Name
Magnesium Hydroxide
Substance Name
Magnesium Hydroxide
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Usage Information
This medication is used for a short time to treat occasional constipation. It is a laxative (osmotic-type) that is thought to work by drawing water into the intestines, an effect that helps to cause movement of the intestines. This medication is also used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. It is an antacid that works by lowering the amount of acid in the stomach.

Regulatory & Marketing

Labeler Name
Belleview Biosciences Llc
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
09-01-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84447-113-01 identifies a specific commercial package of 16000000 mg in 1 drum of Magnesium Hydroxide (UNFINISHED drug), a bulk ingredient labeled by Belleview Biosciences Llc. This suspension is formulated for use and contains magnesium hydroxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Belleview Biosciences Llc on September 01, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used for a short time to treat occasional constipation. It is a laxative (osmotic-type) that is thought to work by drawing water into the intestines, an effect that helps to cause movement of the intestines. This medication is also used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. It is an antacid that works by lowering the amount of acid in the stomach.

How is this Belleview Biosciences Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84447011301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84447-113-01
11-Digit CMS (5-4-2)
84447-0113-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.